Literature DB >> 26494808

Mechanisms Linking Glucose Homeostasis and Iron Metabolism Toward the Onset and Progression of Type 2 Diabetes.

José Manuel Fernández-Real1, Donald McClain2, Melania Manco3.   

Abstract

OBJECTIVE: The bidirectional relationship between iron metabolism and glucose homeostasis is increasingly recognized. Several pathways of iron metabolism are modified according to systemic glucose levels, whereas insulin action and secretion are influenced by changes in relative iron excess. We aimed to update the possible influence of iron on insulin action and secretion and vice versa. RESEARCH DESIGN AND METHODS: The mechanisms that link iron metabolism and glucose homeostasis in the main insulin-sensitive tissues and insulin-producing β-cells were revised according to their possible influence on the development of type 2 diabetes (T2D).
RESULTS: The mechanisms leading to dysmetabolic hyperferritinemia and hepatic overload syndrome were diverse, including diet-induced alterations in iron absorption, modulation of gluconeogenesis, heme-mediated disruption of circadian glucose rhythm, impaired hepcidin secretion and action, and reduced copper availability. Glucose metabolism in adipose tissue seems to be affected by both iron deficiency and excess through interaction with adipocyte differentiation, tissue hyperplasia and hypertrophy, release of adipokines, lipid synthesis, and lipolysis. Reduced heme synthesis and dysregulated iron uptake or export could also be contributing factors affecting glucose metabolism in the senescent muscle, whereas exercise is known to affect iron and glucose status. Finally, iron also seems to modulate β-cells and insulin secretion, although this has been scarcely studied.
CONCLUSIONS: Iron is increasingly recognized to influence glucose metabolism at multiple levels. Body iron stores should be considered as a potential target for therapy in subjects with T2D or those at risk for developing T2D. Further research is warranted.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26494808     DOI: 10.2337/dc14-3082

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  56 in total

1.  Adipose Tissue Transferrin and Insulin Resistance.

Authors:  Donald A McClain; Neeraj K Sharma; Shalini Jain; Alexandria Harrison; Lipika N Salaye; Mary E Comeau; Carl D Langefeld; Felipe R Lorenzo; Swapan K Das
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

2.  Genome-wide association study of iron traits and relation to diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL): potential genomic intersection of iron and glucose regulation?

Authors:  Laura M Raffield; Tin Louie; Tamar Sofer; Deepti Jain; Eli Ipp; Kent D Taylor; George J Papanicolaou; Larissa Avilés-Santa; Leslie A Lange; Cathy C Laurie; Matthew P Conomos; Timothy A Thornton; Yii-Der Ida Chen; Qibin Qi; Scott Cotler; Bharat Thyagarajan; Neil Schneiderman; Jerome I Rotter; Alex P Reiner; Henry J Lin
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

3.  The Role of Insulin Therapy in Correcting Hepcidin Levels in Patients with Type 2 Diabetes Mellitus.

Authors:  Driton Vela; Jovica Leshoski; Elizabeta S Gjorgievska; Nikola Hadzi-Petrushev; Muharrem Jakupaj; Ramadan B Sopi; Mitko Mladenov
Journal:  Oman Med J       Date:  2017-05

4.  Plasma ferritin concentration is positively associated with in vivo fatty acid mobilization and insulin resistance in obese women.

Authors:  Benjamin J Ryan; Douglas W Van Pelt; Lisa M Guth; Alison C Ludzki; Rachel A Gioscia-Ryan; Chiwoon Ahn; Katherine L Foug; Jeffrey F Horowitz
Journal:  Exp Physiol       Date:  2018-10-08       Impact factor: 2.969

5.  Iron down-regulates leptin by suppressing protein O-GlcNAc modification in adipocytes, resulting in decreased levels of O-glycosylated CREB.

Authors:  Yan Gao; Jingfang Liu; Zhenzhong Bai; Sandy Sink; Chengyu Zhao; Felipe Ramos Lorenzo; Donald A McClain
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

6.  Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice.

Authors:  Matthew A Stroh; Michelle K Winter; Russell H Swerdlow; Kenneth E McCarson; Hao Zhu
Journal:  Metab Brain Dis       Date:  2016-05-18       Impact factor: 3.584

7.  Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study.

Authors:  M Angeles Zulet; Itziar Abete; Cristina Galarregui; Irene Cantero; Bertha Araceli Marin-Alejandre; J Ignacio Monreal; Mariana Elorz; Alberto Benito-Boillos; José Ignacio Herrero; Víctor de la O; Miguel Ruiz-Canela; Helen Hermana M Hermsdorff; Josefina Bressan; Josep A Tur; J Alfredo Martínez
Journal:  Eur J Nutr       Date:  2020-08-28       Impact factor: 5.614

Review 8.  Dietary iron intake, iron status, and gestational diabetes.

Authors:  Cuilin Zhang; Shristi Rawal
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

9.  Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome.

Authors:  Büşra Başar Gökcen; Yasemin Akdevelioğlu; Sultan Canan; Nuray Bozkurt
Journal:  Eat Weight Disord       Date:  2020-08-08       Impact factor: 4.652

10.  Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model.

Authors:  Mlindeli Gamede; Lindokuhle Mabuza; Phikelelani Ngubane; Andile Khathi
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-01       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.